Introduction Obesity is a chronic disease, which has significant health consequences and is
a staggering burden to health care systems. Obesity can have harmful effects on the …

Anticoagulation therapy is recommended for patients with non-valvular atrial fibrillation
(NVAF) and an increased risk of stroke. Although apixaban showed superiority over warfarin …

2 by body weight future controlled studies are required to validate the notion that the
independence of AF recurrence rate from body weight specifically applies to CBA. Until then …

2 finding was that DOAC use consistently led to lower bleeding rates than warfarin, with
comparable effects on cardiovascular risk and mortality, and that safety and efficacy was …

2 effective stroke prevention in AF are comprehensively discussed by Barnes et al.[13], who
reported from the global anticoagulation round table. A key message arising from the …